Evidence map›Paper›PMID 23678987›Full record

ArticleJournal of biomedical science2013

Control of post-translational modifications in antithrombin during murine post-natal development by miR-200a.

Raúl Teruel, Irene Martínez-Martínez, José A Guerrero, Rocío González-Conejero, María E de la Morena-Barrio, Salam Salloum-Asfar, Ana B Arroyo, Sonia Águila, Nuria García-Barberá, Antonia Miñano and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of biomedical science, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Raúl TeruelCentro Regional de Hemodonación, University of Murcia, IMIB, Spain, C/Ronda de Garay S/N, 30003, Murcia, Spain.
Irene Martínez-Martínez
José A Guerrero
Rocío González-Conejero
María E de la Morena-Barrio
Salam Salloum-Asfar
Ana B Arroyo
Sonia Águila
Nuria García-Barberá
Antonia Miñano
Vicente Vicente
Javier Corral
Constantino Martínez
Centro Regional de Hemodonación · ESUniversidad de Murcia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDevelopmental haemostatic studies may help identifying new elements involved in the control of key haemostatic proteins like antithrombin, the most relevant endogenous anticoagulant.

resultsIn this study, we showed a significant reduction of sialic acid content in neonatal antithrombin compared with adult antithrombin in mice. mRNA levels of St3gal3 and St3gal4, two sialyltransferases potentially involved in antithrombin sialylation, were 85% lower in neonates in comparison with adults. In silico analysis of miRNAs overexpressed in neonates revealed that mir-200a might target these sialyltransferases. Moreover, in vitro studies in murine primary hepatocytes sustain this potential control.

conclusionsThese data suggest that in addition to the direct protein regulation, microRNAs may also modulate qualitative traits of selected proteins by an indirect control of post-translational processes.

Indexed as

Protein Processing, Post-TranslationalAge FactorsAnimalsAnimals, NewbornAntithrombinsbeta-Galactoside alpha-2,3-SialyltransferaseGene Expression ProfilingHepatocytesMiceMicroRNAsN-Acetylneuraminic AcidRNA, MessengerSialyltransferasesAntithrombinsbeta-Galactoside alpha-2,3-SialyltransferaseMicroRNAsMirn200 microRNA, mouseN-Acetylneuraminic AcidRNA, MessengerSialyltransferases

Identifiers

PMID23678987
PMCPMC3674942
OpenAlexW2148058741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.